(Q50888620)

English

Randomized, controlled trial of RheothRx (poloxamer 188) in patients with suspected acute myocardial infarction. RheothRx in Myocardial Infarction Study Group.

scientific article published in May 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/9588408

Randomized, controlled trial of RheothRx (poloxamer 188) in patients with suspected acute myocardial infarction. RheothRx in Myocardial Infarction Study Group. (English)

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/9588408

myocardial infarction

1 reference

based on heuristic

inferred from title

Charles Maynard

1

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/9588408

Alfred P. Hallstrom

5

object named as

Hallstrom AP

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/9588408

W. Douglas Weaver

7

object named as

Weaver WD

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/9588408

author name string

Swenson R

2

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/9588408

Paris JA

3

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/9588408

Martin JS

4

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/9588408

Cerqueira MD

6

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/9588408

language of work or name

0 references

publication date

1 May 1998

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/9588408

American Heart Journal

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/9588408

135

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/9588408

5 Pt 1

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/9588408

797-804

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/9588408

Importance of early initiation of intravenous streptokinase therapy for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970037-7

7 January 2021

Relation between symptom duration before thrombolytic therapy and final myocardial infarct size

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970037-7

7 January 2021

A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970037-7

7 January 2021

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970037-7

7 January 2021

Effect of age on use of thrombolytic therapy and mortality in acute myocardial infarction. The MITI Project Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970037-7

7 January 2021

Outcome of patients with acute myocardial infarction who are ineligible for thrombolytic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970037-7

7 January 2021

The Western Washington Myocardial Infarction Registry and Emergency Department Tissue Plasminogen Activator Treatment Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970037-7

7 January 2021

Reduction of myocardial infarct size by poloxamer 188 and mannitol in a canine model

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970037-7

7 January 2021

Hyperoxic reperfusion is required to reduce infarct size after intravenous therapy with perfluorochemical (Fluosol-DA 20%) or its detergent component (poloxamer 188) in a poorly collateralized animal model. Absence of a role of polymorphonuclear leu

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970037-7

7 January 2021

Reduction in reperfusion-induced myocardial necrosis in dogs by RheothRx injection (poloxamer 188 N.F.), a hemorheological agent that alters neutrophil function

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970037-7

7 January 2021

Beneficial effects of RheothRx injection in patients receiving thrombolytic therapy for acute myocardial infarction. Results of a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970037-7

7 January 2021

Poloxamer-188 as an adjunct to primary percutaneous transluminal coronary angioplasty for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970037-7

7 January 2021

Identifiers

10.1016/S0002-8703(98)70037-7

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/9588408

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/9588408

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50888620&oldid=2094648262"